OtherTheranostics
Peptide Receptor Radionuclide Therapy of Late-stage Neuroendocrine Tumor Patients with Multiple Cycles of 177Lu-DOTA-EB-TATE
Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Cheng, Zhaohui Zhu and Xiaoyuan Chen
Journal of Nuclear Medicine August 2020, jnumed.120.248658; DOI: https://doi.org/10.2967/jnumed.120.248658
Qingxing Liu
1 Peking Union Medical College, China;
Jie Zang
1 Peking Union Medical College, China;
Huimin Sui
1 Peking Union Medical College, China;
Jiakun Ren
1 Peking Union Medical College, China;
Hua Guo
1 Peking Union Medical College, China;
Hao Wang
1 Peking Union Medical College, China;
Rongxi Wang
1 Peking Union Medical College, China;
Orit Jacobson
2 National Institutes of Health, USA
Jingjing Zhang
1 Peking Union Medical College, China;
Yuejuan Cheng
1 Peking Union Medical College, China;
Zhaohui Zhu
1 Peking Union Medical College, China;
Xiaoyuan Chen
2 National Institutes of Health, USA

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 4
April 1, 2025
Peptide Receptor Radionuclide Therapy of Late-stage Neuroendocrine Tumor Patients with Multiple Cycles of 177Lu-DOTA-EB-TATE
Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Cheng, Zhaohui Zhu, Xiaoyuan Chen
Journal of Nuclear Medicine Aug 2020, jnumed.120.248658; DOI: 10.2967/jnumed.120.248658
Peptide Receptor Radionuclide Therapy of Late-stage Neuroendocrine Tumor Patients with Multiple Cycles of 177Lu-DOTA-EB-TATE
Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Cheng, Zhaohui Zhu, Xiaoyuan Chen
Journal of Nuclear Medicine Aug 2020, jnumed.120.248658; DOI: 10.2967/jnumed.120.248658